Skip to main content
Profound Medical Corp. logo

Profound Medical Corp. — Investor Relations & Filings

Ticker · PROF TSX Manufacturing
Open in API
Filings indexed 659 across all filing types
Latest filing 2021-03-02 Annual Report
Country CA Canada
Listing TSX PROF

About Profound Medical Corp.

https://profoundmedical.com/

Profound Medical Corp. is a commercial-stage medical technology company specializing in incision-free ablative therapies. Its core product is TULSA-PRO®, a therapeutic platform designed for the treatment of localized prostate cancer, radiorecurrent prostate cancer, and benign prostatic hyperplasia (BPH). TULSA-PRO utilizes a robotically controlled, transurethral ultrasound ablation procedure guided by real-time Magnetic Resonance (MR) imaging. This system employs closed-loop temperature feedback to ensure precise and customizable tissue ablation, prioritizing patient safety and minimizing complications. The technology merges MR imaging, thermal ultrasound, and robotics to offer a durable and accurate treatment delivery method.

Recent filings

Filing Released Lang Actions
Annual information form - English.pdf
Annual Report Classification · 95% confidence The document is titled 'ANNUAL INFORMATION FORM' for the year ended December 31, 2020, dated March 2, 2021. It contains detailed sections such as corporate structure, business development, risk factors, acquisitions, intellectual property, dividends, capital structure, directors and officers, legal proceedings, audit committee information, and more. The document references financial information prepared according to IFRS and includes forward-looking statements, market and industry data, and detailed corporate disclosures. The length is substantial (15,000 characters), indicating it is a full report rather than a brief announcement. The Annual Information Form (AIF) is a comprehensive disclosure document typically filed annually by Canadian companies, similar in purpose to an annual report but distinct from the 10-K form used in the U.S. Given the detailed nature and comprehensive coverage of corporate and financial information, this document fits best under the category of Annual Report (10-K), which covers official yearly reports with full financial performance and company activity. Although it is an AIF, the closest and most appropriate classification in the provided taxonomy is 10-K (Annual Report). FY 2020
2021-03-02 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Investor Presentation Classification · 95% confidence The document is a detailed presentation by TAAL Distributed Information Technologies Inc. regarding a securities offering, including a preliminary short form prospectus, forward-looking statements, business summary, market and industry data, and non-IFRS financial measures. It discusses the offering of units consisting of common shares and warrants, risks, and business strategy. The document is not a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a simple announcement or certification. It is a detailed investor presentation focused on the offering, business model, and market positioning, which aligns with the definition of an Investor Presentation (IP). The length (15,000 characters) and content support this classification with high confidence.
2021-03-02 English
Annual MD&A - English.pdf
Management Reports Classification · 95% confidence The document is titled 'Management’s Discussion and Analysis' (MD&A) for the years ended December 31, 2020 and 2019. It contains detailed narrative about the company's business overview, forward-looking statements, COVID-19 impact, change in presentation currency, and product descriptions. It references audited consolidated financial statements prepared under IFRS but does not itself contain the full financial statements. The MD&A is a management report explaining financial results, business trends, and outlook, which aligns with the definition of Management Reports (MDA). The document length is substantial (15,000 characters), indicating it is a full report rather than a brief announcement. There is no indication that this is an Annual Report (10-K) or an Interim Report (IR), nor is it a certification or announcement. Therefore, the correct classification is Management Reports (MDA).
2021-03-02 English
News release - English.pdf
Annual Report Classification · 95% confidence The document is a detailed announcement of Profound Medical Corp.'s financial results for the fourth quarter and full year ended December 31, 2020. It includes comprehensive financial data such as revenue, operating expenses, net loss, balance sheets, and statements of loss and comprehensive loss. The presence of detailed financial statements and analysis for a full fiscal year indicates this is a full annual financial report. The document also references the fiscal year 2020 and includes management commentary on results and outlook. There is no indication that this is merely an announcement of a report or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2020
2021-03-02 English
News release - English.pdf
Investor Presentation Classification · 85% confidence The document is a press release announcing that Profound Medical Corp. will participate in upcoming virtual investor conferences. It mentions specific dates and events but does not contain any financial statements, detailed financial analysis, or regulatory filings. There is no indication that this is a transcript of the conference calls, nor is it an earnings release or annual/interim report. The content is focused on investor relations activities and upcoming presentations rather than financial results or governance matters. Therefore, the document best fits the category of an Investor Presentation announcement or update, but since it is only announcing participation and not providing the presentation itself, it aligns most closely with the Investor Presentation (IP) category as it relates to investor-focused communication about company strategy and market position.
2021-02-25 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing Profound Medical's participation in a virtual conference. It contains no financial statements, no detailed financial data, no regulatory filings, no voting results, no management or board changes, no audit information, and no report attachments. It is a corporate announcement about an upcoming event (a fireside chat at a conference). The document length is under 5,000 characters and does not mention any report being attached or published. Therefore, it does not fit into categories like Annual Report, Earnings Release, or Investor Presentation. It is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement that does not fit other specific categories.
2021-02-11 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.